Literature DB >> 10839970

Identification of viable and non-viable Mycobacterium tuberculosis in mouse organs by directed RT-PCR for antigen 85B mRNA.

S R Pai1, J K Actor, E Sepulveda, R L Hunter, C Jagannath.   

Abstract

Mycobacterium tuberculosis (MTB) the causative organism of tuberculosis can remain dormant as a non-culturable organism, reactivate and cause disease in man and animals. There is a need for proof of viability of such organisms in order to understand the process of reactivation. PCR for bacterial DNA cannot distinguish between viable and non-viable bacilli. We have tested a previously described two tube directed reverse transcriptase polymerase chain reaction (RT-PCR) for the detection of mRNA of antigen 85B (Ag85B) of MTB that can distinguish between viable and non-viable organisms. Using a set of external and internal primers for Ag85B, a cDNA amplified product (216 bp) was seen among simulated samples containing only viable cfus at a sensitivity of >10 and <100 cfu/ml. Eucaryotic DNA rich normal mouse lung homogenate did not interfere among these samples. The method amplified the 216 bp product also among cfu positive tissues of naturally infected mice. Finally, in a mouse model of dormancy, direct RT-PCR detected a signal among multiple tissues that were negative for cfus and hence non-culturable. Ag85B is abundantly secreted by MTB and hyper-expressed under stress conditions. Thus the method to identify its mRNA message may be useful to detect viable but dormant bacteria. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10839970     DOI: 10.1006/mpat.2000.0353

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  19 in total

Review 1.  Tuberculosis: latency and reactivation.

Authors:  J L Flynn; J Chan
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

Review 2.  The tuberculosis drug discovery and development pipeline and emerging drug targets.

Authors:  Khisimuzi Mdluli; Takushi Kaneko; Anna Upton
Journal:  Cold Spring Harb Perspect Med       Date:  2015-01-29       Impact factor: 6.915

3.  Detection of mRNA transcripts and active transcription in persistent Mycobacterium tuberculosis induced by exposure to rifampin or pyrazinamide.

Authors:  Y Hu; J A Mangan; J Dhillon; K M Sole; D A Mitchison; P D Butcher; A R Coates
Journal:  J Bacteriol       Date:  2000-11       Impact factor: 3.490

Review 4.  Biofilms and Helicobacter pylori: Dissemination and persistence within the environment and host.

Authors:  Steven L Percival; Louise Suleman
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

5.  Mycobacterium tuberculosis origin of replication and the promoter for immunodominant secreted antigen 85B are the targets of MtrA, the essential response regulator.

Authors:  Malini Rajagopalan; Renata Dziedzic; Maha Al Zayer; Dorota Stankowska; Marie-Claude Ouimet; D Patrick Bastedo; Gregory T Marczynski; Murty V Madiraju
Journal:  J Biol Chem       Date:  2010-03-11       Impact factor: 5.157

6.  Molecular Bacterial Load Assay Concurs with Culture on NaOH-Induced Loss of Mycobacterium tuberculosis Viability.

Authors:  Bariki Mtafya; Wilber Sabiiti; Issa Sabi; Joseph John; Emanuel Sichone; Nyanda E Ntinginya; Stephen H Gillespie
Journal:  J Clin Microbiol       Date:  2019-06-25       Impact factor: 5.948

7.  Complex pattern of Mycobacterium marinum gene expression during long-term granulomatous infection.

Authors:  Kaman Chan; Timothy Knaak; Laura Satkamp; Olivier Humbert; Stanley Falkow; Lalita Ramakrishnan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

Review 8.  Targeting Phenotypically Tolerant Mycobacterium tuberculosis.

Authors:  Ben Gold; Carl Nathan
Journal:  Microbiol Spectr       Date:  2017-01

Review 9.  Microarray analysis of whole genome expression of intracellular Mycobacterium tuberculosis.

Authors:  Simon J Waddell; Philip D Butcher
Journal:  Curr Mol Med       Date:  2007-05       Impact factor: 2.222

10.  Molecular viability testing of bacterial pathogens from a complex human sample matrix.

Authors:  Kris M Weigel; Kelly L Jones; Julie S Do; Jody Melton Witt; Jae-Hyun Chung; Christian Valcke; Gerard A Cangelosi
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.